Skip to content
10-Q

Quarterly Report

SURFACE ONCOLOGY, INC.

0001718108-23-000013

← back to feed
Filed
May 4, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 1, 2023 60.72M sh
Shares Diluted Q1 2023 · Mar 31, 2023 60.63M sh
Shares Diluted Q1 2023 · Mar 31, 2022 49.82M sh
Capex Q1 2023 · Mar 31, 2023 $17K
Capex Q1 2023 · Mar 31, 2022 $35K
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$23.44M
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$23.57M
Cash And Equivalents Q1 2023 · Mar 31, 2023 $28.98M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $50.91M
Stockholders Equity Q1 2023 · Mar 31, 2023 $75.83M
Stockholders Equity Q1 2023 · Dec 31, 2022 $93.4M
Stockholders Equity Q1 2023 · Mar 31, 2022 $146.99M
Stockholders Equity Q1 2023 · Dec 31, 2021 $118.9M
Current Liabilities Q1 2023 · Mar 31, 2023 $14.75M
Current Liabilities Q1 2023 · Dec 31, 2022 $16.26M
Total Liabilities Q1 2023 · Mar 31, 2023 $61.18M
Total Liabilities Q1 2023 · Dec 31, 2022 $66.51M
Current Assets Q1 2023 · Mar 31, 2023 $107.21M
Current Assets Q1 2023 · Dec 31, 2022 $129.14M
Total Assets Q1 2023 · Mar 31, 2023 $137.01M
Total Assets Q1 2023 · Dec 31, 2022 $159.91M
Eps Diluted Q1 2023 · Mar 31, 2023 −$0.33
Eps Diluted Q1 2023 · Mar 31, 2022 $0.13
Eps Basic Q1 2023 · Mar 31, 2023 −$0.33
Eps Basic Q1 2023 · Mar 31, 2022 $0.13
Rd Expense Q1 2023 · Mar 31, 2023 $13.78M
Rd Expense Q1 2023 · Mar 31, 2022 $16.62M
Net Income Q1 2023 · Mar 31, 2023 −$19.74M
Net Income Q1 2023 · Mar 31, 2022 $6.2M
Operating Income Q1 2023 · Mar 31, 2023 −$19.66M
Operating Income Q1 2023 · Mar 31, 2022 $6.84M
Revenue Q1 2023 · Mar 31, 2023 $0
Revenue Q1 2023 · Mar 31, 2022 $30M